Litcius/Paper detail

Female sex is associated with higher rates of dermatologic adverse events among patients with melanoma receiving immune checkpoint inhibitor therapy: A retrospective cohort study

Ai‐Tram N. Bui, Amina Bougrine, Elizabeth I. Buchbinder, Anita Giobbie‐Hurder, Nicole R. LeBoeuf

2021Journal of the American Academy of Dermatology14 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAdverse effectRetrospective cohort studyMelanomaCohortOncologyInternal medicineDermatologyCancer researchCancer Immunotherapy and BiomarkersCAR-T cell therapy researchImmunotherapy and Immune Responses
Female sex is associated with higher rates of dermatologic adverse events among patients with melanoma receiving immune checkpoint inhibitor therapy: A retrospective cohort study | Litcius